Sorafenib-induced pancreatitis.
Amar
Surabhi
S
Wu
Kevin J
KJ
Tan
Winston W
WW
D000970:Antineoplastic Agents / Q000633:toxicity*; D001557:Benzenesulfonates / Q000633:toxicity*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009536:Niacinamide / Q000031:analogs & derivatives; D010195:Pancreatitis / Q000139:chemically induced*; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000633:toxicity*; D011725:Pyridines / Q000633:toxicity*; D000077157:Sorafenib
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib